We’re studying the BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine) when given during pregnancy.
MotherToBaby is currently enrolling participants in a study that aims to look at the use of the BOOSTRIX Tdap Vaccine during pregnancy. This vaccine is recommended during the 3rd trimester of pregnancy to prevent pertussis (whooping cough) in infants under the age of 2 months. If you have already received the Tdap vaccine during the third trimester of your pregnancy or you plan to do so, we invite you to join our observational study
Please note that we will not ask you to receive the Tdap vaccine as part of the study; we are solely interested in gathering data from those who have already chosen to receive the Tdap vaccine during the third trimester of pregnancy. If you meet this criteria, you may be eligible to participate.
How Our Studies Work
Parent-To-Be Enrolls in Study
We Gather Info about the Pregnancy
Discoveries & Insights Gained
Who Leads MotherToBaby Pregnancy Studies?
Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her research focuses on whether/how medications, vaccines, health conditions, and other exposures during pregnancy affect maternal and infant outcomes.
“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”
– Christina Chambers, PhD, MPH
If you belong to either of these groups, you could qualify to join our study:
People who have received a dose of BOOSTRIX Tdap vaccine during pregnancy or plan to do so.
People who have not received a Tdap vaccine during pregnancy are eligible to join our unexposed control group.
Join Our Study
Your information is confidential.
The BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine) Pregnancy Study conducted by MotherToBaby and is sponsored by GSK.
Questions?
We have answers! We’re open Monday – Friday from 7am – 7pm and Friday 7am – 6pm Pacific, excluding public holidays. To connect with our research team, please contact us at
Phone | 877.311.8972
Email | mothertobaby@health.ucsd.edu
You can also visit our Frequently Asked Questions to learn more about participating in our studies.
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).